Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02650466 · ClinicalTrials.gov registry record · NA
Nanopulse Efficacy Study for the Treatment of Common Warts
A NA study of Common Warts, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT02650466 is a NA study of Common Warts that has completed, run by University of Southern California. The registered enrollment target is 24 participants, below the 149-participant average among 3 other Common Warts trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02650466, a NA study of Common Warts, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if the Nanopulse System can be used to clear common wart lesions on the skin. The Nanopulse System uses a series of low energy, high voltage pulses, each one several billionths of a second in duration, to effectively kill the target tissue contained within the applicator tip electrodes with minimal damage to surrounding tissue. Efficacy and patient outcomes are expected to equal or surpass current treatment modalities in terms of increased ease of use, faster patient healing and minimal scarring with fewer complications resulting from treatment. The device emits significantly less energy than existing electro-surgery or electro-cautery equipment and is believed to be similar to laser therapy treatment of warts. Trained clinicians can usually diagnose warts based by their appearance and location . Non-genital warts are subcategorized into common, periungual, flat, filiform, and plantar types. Common warts are benign, often skin-colored, or brown-grey, rough, bumpy growths on the hands and feet (caused by Human Papilloma Virus type 2) . Common warts in individuals without any immune deficiencies are low risk and are the focus of this study.Based upon the preclinical profile of the Nanopulse device, particularly its safety profile and its effect on transformed cells, it is hypothesized that application of pulses from the Nanopulse System , will result in complete clinical clearance of Common Wart lesions with minimal scarring.
Conditions Studied
Interventions
- DEVICE Nanopulse System
Study Locations (1)
California
- Huntington Medical Foundation - Pasadena
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2013-12 |
| Est. Completion | 2016-09-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02650466
The ClinicalTrials.gov registry entry for NCT02650466 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 149-participant average among 3 other Common Warts trials with a reported enrollment target (84% lower). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Common Warts appearing as the primary indexed condition, and to 1 intervention - of which Nanopulse System is the first listed.
NCT02650466 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02650466 about?
NCT02650466 is a clinical study titled "Nanopulse Efficacy Study for the Treatment of Common Warts". The purpose of this study is to determine if the Nanopulse System can be used to clear common wart lesions on the skin. The Nanopulse System uses a series of low energy, high voltage pulses, each one several billionths of a second in duration, to effectively kill the target tissue contained within t...
What is the current status of trial NCT02650466?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2013-12. Estimated completion is 2016-09-26.
What conditions does trial NCT02650466 study?
This clinical trial studies the following conditions: Common Warts.
What interventions are being tested in trial NCT02650466?
The interventions under investigation include: Nanopulse System (DEVICE).
Who is sponsoring clinical trial NCT02650466?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02650466 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Common Warts
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.